UP

CVS latest to suspend heartburn drug over cancer fears

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto
CVS latest to suspend heartburn drug over cancer fears

US retailer CVS has become the latest to suspend the sale of a heartburn drug being investigated for links to cancer.

Axar.az reports citing BBC.

It follows concern in several countries over the presence of impurities in Zantac and other ranitidine products.

Canada and France have already announced Zantac recalls. The US and the European Union are investigating.

Health authorities say there is no immediate risk, but patients have been advised to consult a doctor who can prescribe alternatives to ranitidine.

Date
2019.09.29 / 17:51
Author
Axar.az
See also

Stop believing these 6 common diet myths - BBC

Over 60 children infected with measles in London

WHO says low risk of Nipah virus spreading beyond India

Asian countries step up airport checks over Nipah virus

Deadly Nipah virus cases reported in India

Robots get human-like “Smart Skin”

WHO warns of rapid spread of "Hong Kong Flu"

Japanese frog bacteria kill cancer cells

Stem cell drug offers non-opioid osteoarthritis pain relief

US develops AI tool for early breast cancer detection

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla